Clinical Trials Search | Clareo Health

Showing 1-2 of 2 trials

COMPASSION S3 Post-Approval Study

NCT04860765

This study will monitor device performance and outcomes of the SAPIEN 3 Transcatheter Heart Valve (THV) System in subjects with a dysfunctional right ventricular outflow tract (RVOT) conduit or previously implanted surgical valve in the pulmonic position with a clinical indication for intervention.

Complex Congenital Heart DefectDysfunctional RVOT ConduitPulmonary Valve Insufficiency+2 more

Edwards Lifesciences150 participantsStarted Apr 2021

Birmingham, Alabama, United States • Los Angeles, California, United States • Aurora, Colorado, United States +16 more locations

Active Not Recruiting

ALTERRA Post-Approval Study

NCT05378386

This study will monitor device performance and outcomes in subjects undergoing implantation of the Edwards SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra Adaptive Prestent in the post-approval setting

Pulmonary Valve InsufficiencyComplex Congenital Heart DefectTetralogy of Fallot+2 more

Edwards Lifesciences150 participantsStarted May 2022

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +21 more locations

Data from ClinicalTrials.govTerms

Filters

Filters

COMPASSION S3 Post-Approval Study

ALTERRA Post-Approval Study

COMPASSION S3 Post-Approval Study

ALTERRA Post-Approval Study